PCN4 DINUTUXIMAB BETA WITH ISOTRETINOIN VERSUS ISOTRETINOIN ALONE IN THE TREATMENT OF HIGH-RISK NEUROBLASTOMA: IMPACT ON LONG-TERM SURVIVAL
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.201
https://www.valueinhealthjournal.com/article/S1098-3015(19)32579-3/fulltext
Section Title :
Section Order :
10151
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32579-3&doi=10.1016/j.jval.2019.09.201